Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Supersoft sponge-like cryogel as an implant to treat glioblastoma

Wang, Yu, Le Joncour, Vadim, Laakkonen, Pirjo and Newland, Ben ORCID: https://orcid.org/0000-0002-5214-2604 2024. Supersoft sponge-like cryogel as an implant to treat glioblastoma. Neuro-Oncology 26 (7) , vii16. 10.1093/neuonc/noae158.064
Item availability restricted.

[thumbnail of SUPERSOFT SPONGE Newland.pdf] PDF - Accepted Post-Print Version
Restricted to Repository staff only until 15 October 2025 due to copyright restrictions.

Download (95kB)
License URL: https://academic.oup.com/pages/standard-publication-reuse-rights
License Start date: 1 October 2024

Abstract

AIMS: Create cylindrical cryogels with well-defined size. Investigate clemastine drug loading capicaty and drug release patterns. Investigate in vitro and in vivo safety and antitumor efficacy. METHOD: A 3D printed template was designed and printed to make cylindrical shape cryogels. The morphology of cryogels was characterized by bright field photos, SEM, FTIR and confocal microscopy photos. The mechanical property was evaluated by uniaxial compression tests. The orthotropic glioblastoma tumor model was established by engrafting BT12 human glioblastoma stem cells intracerebrally into immunocompromised nude mice. The tumor was surgically removed after two weeks and the cryogel was implanted into the resection cavity. Animals were euthanized after two weeks, and their brains were collected for the immunohistochemistry. RESULTS: Cylindrical cryogels were prepared to exactly fit the biopsy resection cavity in the mouse glioblastoma tumor resected model. The macropore structure in the cryogel was observed under confocal microscopy. Young’s modulus of the cryogel was only 1.6 kPa. The loading capacity of clemastine in one cryogel was more than 100 μg. Clemastine could be sustained released for around a week. In vitro cell viability studies showed that empty cryogels were not toxic to the tumor cells and drug loaded cryogels killed the tumor cells in a time and concentration dependent manner. In vivo studies further confirmed that cryogels could be safely implanted into the brain. Although the implantation of clemastine loaded cryogels did not prevent the growth of the primary tumor, it reduced the amount of invasion tumor cells compared with the mice only resected the tumor. CONCLUSION: Cryogels were easily created by the 3D printed templates. The soft material avoided mechanical mismatch with the brain tissue. The cryogel did not show any toxicity in in vitro and in vivo studies, which indicated it would be a promising material to be implanted into the brain.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Pharmacy
Additional Information: License information from Publisher: LICENSE 1: URL: https://academic.oup.com/pages/standard-publication-reuse-rights, Start Date: 2024-10-01
Publisher: Oxford University Press (OUP)
ISSN: 1522-8517
Date of First Compliant Deposit: 11 November 2024
Last Modified: 11 Nov 2024 10:00
URI: https://orca.cardiff.ac.uk/id/eprint/173304

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics